Aarti Pharmalabs Ltd
Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals[1]
- Market Cap ₹ 5,166 Cr.
- Current Price ₹ 570
- High / Low ₹ 663 / 330
- Stock P/E 23.9
- Book Value ₹ 194
- Dividend Yield 0.53 %
- ROCE 16.6 %
- ROE 13.1 %
- Face Value ₹ 5.00
Pros
Cons
- Company has a low return on equity of 13.9% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
0 | 1,200 | 1,945 | 1,853 | |
0 | 993 | 1,603 | 1,467 | |
Operating Profit | 0 | 207 | 342 | 386 |
OPM % | 17% | 18% | 21% | |
0 | 3 | 2 | 5 | |
Interest | 0 | 12 | 21 | 17 |
Depreciation | 0 | 42 | 63 | 73 |
Profit before tax | 0 | 155 | 261 | 300 |
Tax % | 21% | 26% | 28% | |
0 | 122 | 193 | 217 | |
EPS in Rs | 21.35 | 23.93 | ||
Dividend Payout % | 0% | 9% | 13% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 71% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 14% |
Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Equity Capital | 0 | 0 | 45 | 45 |
Reserves | -0 | 1,386 | 1,513 | 1,712 |
0 | 341 | 215 | 285 | |
0 | 312 | 470 | 540 | |
Total Liabilities | 0 | 2,040 | 2,244 | 2,582 |
0 | 782 | 926 | 1,033 | |
CWIP | 0 | 187 | 102 | 137 |
Investments | 0 | 32 | 87 | 107 |
0 | 1,038 | 1,130 | 1,305 | |
Total Assets | 0 | 2,040 | 2,244 | 2,582 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
0 | -44 | 250 | 216 | |
0 | -139 | -158 | -215 | |
0 | 260 | -163 | 10 | |
Net Cash Flow | 0 | 78 | -71 | 12 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Debtor Days | 115 | 84 | 102 | |
Inventory Days | 272 | 188 | 230 | |
Days Payable | 123 | 106 | 135 | |
Cash Conversion Cycle | 264 | 166 | 197 | |
Working Capital Days | 214 | 134 | 163 | |
ROCE % | 19% | 16% | 17% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Jul
- Business Responsibility and Sustainability Reporting (BRSR) 15 Jul
- Record Date For Final Dividend FY 2023-24 Is July 31, 2024 15 Jul
- Notice Of The 5Th Annual General Meeting To Be Held On August 07, 2024 15 Jul
- Reg. 34 (1) Annual Report. 15 Jul
Annual reports
Concalls
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023TranscriptNotesPPT
Business Overview:[1]
Aarti Pharmalabs Limited (APL) formerly known as Aarti Organics was established in 1984 as a WOS of Aarti Industries Limited. Got demerged in Oct,22 into a separately listed entity.
Co. is an internationally recognized manufacturer of generic API & Intermediates, Xanthine derivatives and offers CDMO/CMO services. Company has 6 manufacturing plants and 3 R&D centres.